📰 Finalis Securities News
Finalis Securities News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Finalis Securities. Real-time updates on events, politics, business and more.
December 18, 2023
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal disease clinical pipeline A concurrent institutional...
December 18, 2023
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) (BWB or the “Company”) today announced the acquisition of...
December 18, 2023
CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (NASDAQ:BWV) ("BWB" or the "Company") today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology
May 22, 2023
Labcorp Plans to Develop and Commercialize the Innovative Prostate Cancer Liquid Biopsy Test in the U.S. Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced
August 11, 2022
New Financing to Meet Significant Growth in Global Demand for MolecuLight's i:X and DX Point-of-Care Imaging Devices for the Wound Care Industry TORONTO, Aug. 11, 2022 /PRNewswire/ -- MolecuLight
January 5, 2022
/PRNewswire/ -- Featherweight Capital Partners, an Austin-based independent sponsor, announced its acquisition of Broadcat LLC ("Broadcat"), the leading...
January 5, 2022
/PRNewswire/ -- Featherweight Capital Partners, an Austin-based independent sponsor, announced its acquisition of Broadcat LLC ("Broadcat"), the leading...
November 4, 2021
/PRNewswire/ -- Inflection Partners, LLC ("Inflection Partners," the "Company," or "we"), a capital markets consulting firm, is excited to announce their...
November 4, 2021
/PRNewswire/ -- Inflection Partners, LLC ("Inflection Partners," the "Company," or "we"), a capital markets consulting firm, is excited to announce their...